Physician

Robert Douglas Haydel, M.D.

According to 2025 Medicare claims, Robert Haydel, M.D. (NPI: 1891791240) practices allergy/immunology in the Houma-Bayou Cane-Thibodaux, LA market, with the plurality of this provider's patient population coming from Terrebonne, LA. This provider's primary affiliated billing organization is HAYDEL ASTHMA & ALLERGY CLINIC (NPI: 1184708661) and primary practice location at 70360-2810.

Haydel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 50 traditional Medicare patients, billed 8,145 HCPCS/CPT codes, and received $230,973 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 665 prescription claims across 102 beneficiaries totaling $477,576 in drug costs, led by Xolair (Omalizumab). DME data shows 61 claims. Open Payments data shows 9 records totaling $279. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $28,747 to $477,576. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $1,421 to $1,444.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$155K$311K2015 Medicare payment: $233,884 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $267,039 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $239,523 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $310,711 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $230,682 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $258,704 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $244,749 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $227,047 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $221,173 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $230,973 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156910,231$233,884
20168310,754$267,039
2017718,910$239,523
20187810,679$310,711
2019807,852$230,682
2020728,555$258,704
2021638,772$244,749
2022747,690$227,047
2023607,671$221,173
2024508,145$230,973

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$239K$478K2015 Drug cost: $28,747 (USD; Tot_Drug_Cst)2016 Drug cost: $28,990 (USD; Tot_Drug_Cst)2017 Drug cost: $37,768 (USD; Tot_Drug_Cst)2018 Drug cost: $35,789 (USD; Tot_Drug_Cst)2019 Drug cost: $49,126 (USD; Tot_Drug_Cst)2020 Drug cost: $50,239 (USD; Tot_Drug_Cst)2021 Drug cost: $86,599 (USD; Tot_Drug_Cst)2022 Drug cost: $176,902 (USD; Tot_Drug_Cst)2023 Drug cost: $243,977 (USD; Tot_Drug_Cst)2024 Drug cost: $477,576 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201564319$28,747
201670337$28,990
201764367$37,768
201870451$35,789
201982467$49,126
202084475$50,239
2021105713$86,599
2022116731$176,902
2023106670$243,977
2024102665$477,576

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$18K$36K2015 Medicare payment: $17,506 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $19,485 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $15,536 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $36,260 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $34,482 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $34,283 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $22,153 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $7,100 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $4,538 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $3,254 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R130$17,506
2016N/R170$19,485
2017N/R144$15,536
201830292$36,260
201923270$34,482
202028254$34,283
2021N/R201$22,153
202212142$7,100
2023N/R76$4,538
2024N/R61$3,254

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more1212$103
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3862$75
96372Injection of drug or substance under skin or into muscle18425$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XolairOmalizumab651,820$316,781
Trelegy ElliptaFluticasone/Umeclidin/Vilanter521,920$41,177
Breo ElliptaFluticasone/Vilanterol29870$11,736
Ipratropium BromideIpratropium Bromide792,437$2,216
Fluticasone PropionateFluticasone Propionate923,011$1,104

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 microgramsNN/R12$1,862
Q0513Pharmacy dispensing fee for inhalation drug(s); per 30 daysNN/R26$673
J7626Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mgNN/R12$653
J7614Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mgNN/R11$66

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$279GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert Douglas Haydel, M.D.?

Tedicare shows public-source Medicare data for Robert Douglas Haydel, M.D. (NPI 1891791240), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Douglas Haydel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Douglas Haydel, M.D.?

Robert Douglas Haydel, M.D. is linked to HAYDEL ASTHMA & ALLERGY CLINIC (billing NPI 1184708661) in the available physician profile data.

Does Robert Douglas Haydel, M.D. have Open Payments data?

Robert Douglas Haydel, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.